Prevalence and distribution of ret/ptc 1, 2, and 3 in papillary thyroid carcinoma in New Caledonia and Australia

被引:43
作者
Chua, EL
Wu, WM
Tran, KT
McCarthy, SW
Lauer, CS
Dubourdieu, D
Packham, N
O'Brien, CJ
Turtle, JR
Dong, QH
机构
[1] Univ Sydney, Dept Med, Sydney, NSW 2006, Australia
[2] Royal Prince Alfred Hosp, Dept Anat Pathol, Sydney, NSW 2006, Australia
[3] Royal Prince Alfred Hosp, Dept Head & Neck Surg, Sydney, NSW 2006, Australia
[4] Dr Lauer Pathol, Sydney, NSW 2006, Australia
[5] Lab Anat & Cytol Pathol, Noumea 98846, New Caledonia
关键词
D O I
10.1210/jc.85.8.2733
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The world's highest incidence of thyroid cancer has been reported among females in New Caledonia, a French overseas territory in the Pacific located between Australia and Fiji. To date, no molecular genetic studies in this population are available. Over the past few years, the oncogenic rearrangement of the ret protooncogene (ret/ptc) has been studied in papillary carcinomas in different populations. In this study, we investigated the prevalence and distribution of ret/ptc1, 2, and 3 in papillary thyroid carcinoma from the New Caledonian population and compared the pattern with that of an Australian population. Fresh-frozen and paraffin-embedded papillary carcinomas from 27 New Caledonian and 20 Australian patients were examined for ret rearrangements by means of RT-PCR with primers flanking the chimeric region, followed by hybridization with radioactive probes. ret/ptc was present in 70% of the New Caledonian and in 85% of the Australian samples. Multiple rearrangements were detected and confirmed by sequencing in 19 cases, 4 of which had 3 types of rearrangements in the same tumor. This study demonstrates a high prevalence of ret/ptc in New Caledonian and Australian papillary carcinoma. The findings of multiple ret/ptc in the same tumor suggest that some thyroid neoplasms may indeed be polyclonal.
引用
收藏
页码:2733 / 2739
页数:7
相关论文
共 41 条
[1]   INCIDENCE OF THYROID-CANCER IN NEW-CALEDONIA, SOUTH-PACIFIC, DURING 1985-1992 [J].
BALLIVET, S ;
SALMI, LR ;
DUBOURDIEU, D ;
BACH, F .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 141 (08) :741-746
[2]  
BALLIVET S, 1999, RAD THYROID CANC, P107
[3]   Thyroid cancer in the Pacific [J].
Blot, WJ ;
LeMarchand, L ;
Boice, JD ;
Henderson, BE .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (01) :90-91
[4]  
Bongarzone I, 1998, CLIN CANCER RES, V4, P223
[5]   Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma [J].
Bongarzone, I ;
Fugazzola, L ;
Vigneri, P ;
Mariani, L ;
Mondellini, P ;
Pacini, F ;
Basolo, F ;
Pinchera, A ;
Pilotti, S ;
Pierotti, MA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (05) :2006-2009
[6]   High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation [J].
Bounacer, A ;
Wicker, R ;
Caillou, B ;
Cailleux, AF ;
Sarasin, A ;
Schlumberger, M ;
Suarez, HG .
ONCOGENE, 1997, 15 (11) :1263-1273
[7]  
COATES M, 1999, CANC NEW S WALES INC
[8]   Neurturin shares receptors and signal transduction pathways with glial cell line-derived neurotrophic factor in sympathetic neurons [J].
Creedon, DJ ;
Tansey, MG ;
Baloh, RH ;
Osborne, PA ;
Lampe, PA ;
Fahrner, TJ ;
Heuckeroth, RO ;
Milbrandt, J ;
Johnson, EM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (13) :7018-7023
[9]   GDNF signalling through the Ret receptor tyrosine kinase [J].
Durbec, P ;
MarcosGutierrez, CV ;
Kilkenny, C ;
Grigoriou, M ;
Wartiovaara, K ;
Suvanto, P ;
Smith, D ;
Ponder, B ;
Costantini, F ;
Saarma, M ;
Sariola, H ;
Pachnis, V .
NATURE, 1996, 381 (6585) :789-793
[10]   CLONAL ANALYSIS OF HUMAN TUMORS WITH M27-BETA, A HIGHLY INFORMATIVE POLYMORPHIC-X CHROMOSOMAL PROBE [J].
FEY, MF ;
PETER, HJ ;
HINDS, HL ;
ZIMMERMANN, A ;
LIECHTIGALLATI, S ;
GERBER, H ;
STUDER, H ;
TOBLER, A .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (05) :1438-1444